MedPath
FDA Approval

CISplatin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Apotex Corp.
DUNS: 845263701
Effective Date
December 21, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Cisplatin(50 mg in 50 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)

Apotex Corp.

544532200

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CISplatin

Product Details

NDC Product Code
60505-6277
Route of Administration
INTRAVENOUS
Effective Date
December 21, 2023
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
CisplatinActive
Code: Q20Q21Q62JClass: ACTIBQuantity: 50 mg in 50 mL
© Copyright 2025. All Rights Reserved by MedPath